EN PL
  1. www.sciencepharma.com
  2. News
  3. Polish Law
  4. URPL: Announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products concerning amendment of fees related to marketing authorization of a medicinal product.

URPL: Announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products concerning amendment of fees related to marketing authorization of a medicinal product.

02.01.2014
This document is an announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products concerning amendment of fees related to marketing authorization of a medicinal product.
The source of the news: http://www.urpl.gov.pl/aktualnosci/komunikat-prezesa-urzedu-z-dnia-2-stycznia-2014-r-w-sprawie-zmiany-od-dnia-1-stycznia-2014-r-wysokosci-oplat-zwiazanych-z-dopuszczeniem-do-obrotu-prod